News & Perspectives

In July 2026, I completed the IMD Board Readiness Diploma at IMD's Global Board Center in Lausanne.

Governance is a discipline in its own right, distinct from, but built on, operational experience. This adds a formal foundation to the board and advisory work I do across the off-patent medicines sector.

Grateful to IMD's faculty for the program, and to everyone who continues to back me in this next chapter of my professional life.

It is a transition grounded in twenty-five years in the off-patent medicines industry across Europe, Asia Pacific and MENA — the last seven at Zentiva, leading commercial operations across Western Europe as part of the executive team.

The non-compete over the past twelve months gave structure to what turned out to be a genuinely valuable pause. Time to reflect, to learn, to prepare — for what comes next.

Advise. Transform. Invest.

Looking forward to being back in the room.

Proud to have been part of this journey over the past seven years. Building the Western Europe organisation from a carve-out, expanding into new markets, broadening the portfolio and executing a targeted acquisition strategy. In short, building a resilient, value-creating platform.

Exciting to see what comes next.

Read the full announcement at zentiva.com ↗